DFX Intelligence
Octave Bioscience Inc
Venture-backed company · Stage unknown· Menlo Park, CA
As of · the latest observation of this company; each round carries its own date
Form D industry: Other Health Care
As of · the latest observation of this company; each round carries its own date
4 additional officers and directors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 1 investornamed
1 investor on record.
The investors already on the cap table shape who leads the next round.
- 7 directorsboard
7 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Drawing the relationship network…
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
2 rounds
- Mar 7, 2025Form D equity offering · $31.8M (form d sold) · 20 investorsFact Form D · “Octave Bioscience Inc filed Form D: $31,840,355 sold of $53,674,121, Other Health Care”
- Nov 26, 2014Form D equity offering · $2.5M (form d sold)Kleiner Perkins via Brook H. ByersFact Form D · “Octave Bioscience Inc Form D, first filed 2017-09-13”
Investors on record
1 edge
- Kleiner Perkins form d related, Brook H. Byers (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.none on record
Outcome stated by investors
No firm portfolio page lists this company, so no outcome is stated.
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.none on record
No lender position matched to this company.
People
2 officers, 7 directors
- Doug Biehn Executive Officer/Director sec.gov
- Marcel Konrad Executive Officer sec.gov
- A. Grant Heidrich III Director Fact
- George Scangos Director Fact
- William Hagstrom Director Fact
Timeline
1 event
- Mar 24, 2025Octave Bioscience Inc filed Form D: $31,840,355 sold of $53,674,121, Other Health CareForm D filed Fact Form D
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Mar 24, 2025 Fact Form D
- Form D industry group: Other Health Care Mar 24, 2025 Fact Form D
- Amendment: false Mar 24, 2025 Fact Form D
- Revenue range (Form D): Decline to Disclose Mar 24, 2025 Fact Form D
- Incorporated: overFiveYears Mar 24, 2025 Fact Form D
- Jurisdiction: Delaware Mar 24, 2025 Fact Form D
- Amount sold (Form D): $31.8M Mar 24, 2025 Fact Form D
- Offering amount (Form D): $53.7M Mar 24, 2025 Fact Form D
- Exemptions: 06b Mar 24, 2025 Fact Form D
- First sale: 2025-03-07 Mar 24, 2025 Fact Form D
- Investors (Form D): 20 Mar 24, 2025 Fact Form D
- Minimum investment (Form D): 0 Mar 24, 2025 Fact Form D
- Securities offered: equity Mar 24, 2025 Fact Form D
- Office address: Mar 24, 2025 Fact Form D
Record history
1 dated event on the change ledger, latest event first
- Form D filed2025-03-24source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.